138 related articles for article (PubMed ID: 37391753)
1. Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda.
Rurangwa C; Ndayisenga J; Sezirahiga J; Nyirimigabo E
BMC Health Serv Res; 2023 Jun; 23(1):717. PubMed ID: 37391753
[TBL] [Abstract][Full Text] [Related]
2. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
3. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
4. Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan.
Sarwar MR; Iftikhar S; Saqib A
BMC Cancer; 2018 Jan; 18(1):14. PubMed ID: 29298681
[TBL] [Abstract][Full Text] [Related]
5. Availability and affordability of biologic versus non-biologic anticancer medicines: a cross-sectional study in Punjab, Pakistan.
Saqib A; Iftikhar S; Sarwar MR
BMJ Open; 2018 Jun; 8(6):e019015. PubMed ID: 29903783
[TBL] [Abstract][Full Text] [Related]
6. Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia.
Hailu AD; Mohammed SA
BMC Med Inform Decis Mak; 2020 Sep; 20(1):221. PubMed ID: 32917201
[TBL] [Abstract][Full Text] [Related]
7. Availability and affordability of priority lifesaving maternal health medicines in Addis Ababa, Ethiopia.
Dinkashe FT; Haile K; Adem FM
BMC Health Serv Res; 2022 Apr; 22(1):524. PubMed ID: 35443654
[TBL] [Abstract][Full Text] [Related]
8. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
10. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
Babar ZU; Lessing C; Mace C; Bissell K
Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
[TBL] [Abstract][Full Text] [Related]
11. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
12. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
Sisay M; Amare F; Hagos B; Edessa D
J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
[TBL] [Abstract][Full Text] [Related]
13. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
[TBL] [Abstract][Full Text] [Related]
14. Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey.
Mohammed SA; Tsehay T; Faris AG; Mengstu G
PLoS One; 2022; 17(12):e0279465. PubMed ID: 36542641
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
16. Accessibility of essential anticancer medicines for children in the Sichuan Province of China.
Chen Z; Li S; Zou K; Li H; Zeng L; Lu X; Jia ZJ; Cheng G; Zhang L
Front Public Health; 2022; 10():980969. PubMed ID: 36408013
[TBL] [Abstract][Full Text] [Related]
17. Influence of inventory management practices on the availability of emergency obstetric drugs in Rwandan public hospitals: a case of Rwanda Southern Province.
Kabera JC; Mukanyangezi MF
BMC Health Serv Res; 2024 Jan; 24(1):14. PubMed ID: 38178088
[TBL] [Abstract][Full Text] [Related]
18. Antivenom for sale? Availability and affordability of snakebite medicines across public and private health facilities in Rwanda.
Schurer JM; Murara E; van Oirschot J; Ooms G
Toxicon; 2023 Oct; 234():107292. PubMed ID: 37734455
[TBL] [Abstract][Full Text] [Related]
19. Availability and affordability of antimalarial and antibiotic medicines in Malawi.
Khuluza F; Heide L
PLoS One; 2017; 12(4):e0175399. PubMed ID: 28419126
[TBL] [Abstract][Full Text] [Related]
20. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]